Hepatic arterial chemotherapy for colorectal liver metastases

Hepato-Gastroenterology

Volumn 48, Issue 38, 2001, Pages 317-319

  Mathur, P ^a   Allen Mersh, T G ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Colorectal liver metastasis; Hepatic arterial chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; FLOXURIDINE; FLUOROURACIL DERIVATIVE;

ARTERY CATHETER; CANCER CHEMOTHERAPY; COLORECTAL CANCER; DRUG INFUSION; DRUG RESPONSE; HEALTH CARE COST; LIVER METASTASIS; LIVER TOXICITY; MORBIDITY; MORTALITY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PUMP; QUALITY OF LIFE; REVIEW; TREATMENT CONTRAINDICATION;

ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS;

EID: 0035042015     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Improving survival after large bowel cancer: Surgeons should look for the occult. Leader
2. Resection of hepatic metastases from colorectal cancer
3. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate
4. Vascularisation of small liver metastases
5. Applications of dose intensity to problems in chemotherapy of breast and colorectal cancer
6. A Clinical-Pharmacological evaluation of hepatic arterial infusions of 5-Fluoro-2-deoxyuridine and 5 Fluorouracil
7. Regional chemotherapy devices: Effect of experience and anatomy on complications
8. Update on hepatic intraarterial chemotherapy
9. Effect of aberrant hepatic arterial anatomy on tumor response to regional floxuridine infusion for colorectal liver metastases
10. Treatment interruptions and complications with two continuous hepatic artery floxuridine infusion systems in colorectal liver metastases
11. Hepatic arterial cannulation for regional chemotherapy is safe in patients with a liver metastasis volume of <1L
12. Quality of life and survival with continuous hepatic artery floxuridine infusion for colorectal liver metastases
13. Importance of hepatic artery node involvement in patients with colorectal liver metastases
14. Regional infusion chemotherapy for colorectal liver metastases- where is it going?
15. Measurement of response to treatment in colorectal liver metastases
16. A randomized trial of intrahepatic infusion of FUDR with dexamethasone versus FUDR alone in the treatment of metastatic colon cancer
17. Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma
18. Reappraisal of hepatic arterial infusion in the treatment of non-resectable liver metastases from colorectal cancer
19. Effect of regional and systemic fluorinated pyrimidine chemotherapy on quality of life in colorectal liver metastasis patients
20. Hepatic arterial floxuridine as second-line treatment for systemic fluorouracil-resistant colorectal liver metastases
21. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alpha-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin
22. Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients withunresectable colorectal liver metastases
23. Infusion pumps for systemic and intraarterial chemotherapy of colorectal liver metastases
24. Intraarterial infusion: Overview and novel approaches